Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
August 1, 2024Natural Product CommunicationsOpen Access

Exploring the Potential Pharmacological Basis and Mechanism of HJT Activity in the Treatment of CHD Based on UPLC-QE-MS and Network Pharmacology

View Full Paper
Ask AI
Bookmark
Share

Authors

WQWang QiZJZhong JianyuanWZWenxia Zhang

Discussion

Loading...

Member takes

Overview

Key Points

Key points are not available for this paper at this time.

Cite This Study

Qi et al. (2024) studied this question.

synapsesocial.com/papers/68e5e2b0b6db643587576fdahttps://doi.org/10.1177/1934578x241275005
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Based on Network Pharmacology and RNA Sequencing Techniques to Explore the Molecular Mechanism of Huatan Jiangzhuo Decoction for Treating Hyperlipidemia2021 · 1 citations
  2. 2Network pharmacology‐based screening and pharmacokinetic evaluation of key active compounds in Jinhong tablets against chronic superficial gastritis2025
  3. 3Network Pharmacology and Molecular Docking on the Molecular Mechanism of Jiawei-Huang Lian-Gan Jiang Decoction in the Treatment of Colorectal Adenomas2022 · 3 citations
  4. 4Exploring the Mechanism of Liuwei Jinji'er Tangsan in Preventing and Treating Renal Damage in High‐Altitude Polycythemia Based on UPLC‐Q‐TOF‐MS, Network Pharmacology, and Molecular Docking2026
  5. 5Pharmacodynamic material basis and mechanism of Tenghuang Jiangu Wan on osteoarthritis using UPLC-Q-TOF-MS integrated with target network pharmacology2024 · 1 citations